Results show that all patients with SLE had a lower frequency of CD8+ and CD4+ Spike–specific T cells than HC throughout the vaccination series (Figure 3, A and B; P < 0.05 by Mann-Whitney U test). The gene discussed is CD8A; the disease is systemic lupus erythematosus.